Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma

Published:2006-09 Issue:3 Volume:77 Page:226-232
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Nishio Mitsufumi,Fujimoto Katsuya,Yamamoto Satoshi,Endo Tomoyuki,Sakai Toshiya,Obara Masato,Kumano Kohki,Minauchi Koichiro,Yamaguchi Keisuke,Takeda Yukari,Sato Norihiro,Koizumi Kazuki,Mukai Masaya,Koike Takao

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2006.00693.x/fullpdf

Reference26 articles.

1. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.

2. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

3. International Consensus Conference on High-Dose Therapy With Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report of the Jury

4. Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors for Persistent Hypogammaglobulinemia After Rituximab Therapy in Pediatric Patients;2024-05-30

2. Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect;International Journal of Molecular Sciences;2023-11-06

3. Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab;Annals of Allergy, Asthma & Immunology;2023-06

4. Acquired B-cell deficiency secondary to B-cell-depleting therapies;Journal of Immunological Methods;2022-12

5. Secondary rituximab‐associated versus primary immunodeficiencies: The enigmatic border;European Journal of Immunology;2022-08-10